Effects of HMG-CoA Reductase Inhibitors on Primary Hypertension Patients with Vascular Cognitive Impairment

刘翀,曾春来,郑良荣

2010-01-01

Abstract:OBJECTIVE To assess the effects of blood pressure lowering treatments for the prevention of cognitive decline on primary hypertension patients with vascular cognitive impairment,and to investigate whether those patients could benefit from the treatment of atorvastatin in addition to blood pressure lowering treatments.METHODS 143 primary hypertension patients with vascular cognitive impairment were allocated into three groups.Patients in Group A (n=57),with hypercholesterolemia,undertook blood pressure lowering treatments and atorvastatin.The others,with normal plasma cholesterol levels,were randomly divided into two subgroups.Patients in Group B1 (n=42),undertook blood pressure lowering treatments and placebo.Patients in Group B2 (n=44),undertook blood pressure lowering treatments and atorvastatin.At baseline and 1 year after treatment,cognitive function was evaluated by using MMSE scale,ADAS-cog scale and SF-36 scale.RESULTS After treatment,all patients had significantly increase on the MMSE scores and the SF-36 scores between the baseline scores and the final socres,and they also had significantly decrease on the ADAS-cog scores.There were no significant difference in the alteration of the MMSE scores and the ADAS-cog scores between Group B1 and Group B2.The increase of the SF-36 scores in Group B2 was more significant than Group B1.The increase of the MMSE scores and the SF-36 scores in Group A were more significant than those of Group B2.And the decreases of the ADAS-cog scores in Group A was more significant than those of Group B2.CONCLUSION Blood pressure lowering treatments can improve cognitive function and life quality in primary hypertension patients with vascular cognitive impairment.Primary hypertension patients with normal plasma cholesterol levels can not have more benefit to cognitive function from the the treatment of atorvastatin in addition to blood pressure lowering treatments,in spite of improving the life quality.However,primary hypertension patients with hypercholesterolemia can have more benefit to cognitive function from the the treatment of atorvastatin in addition to blood pressure lowering treatments.